MariMed Inc.
MRMD
$0.093
-$0.002-2.11%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.26% | 4.62% | 10.73% | 10.33% | 8.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.26% | 4.62% | 10.73% | 10.33% | 8.57% |
| Cost of Revenue | 21.83% | 8.43% | 16.81% | 13.00% | 7.81% |
| Gross Profit | -26.61% | -0.36% | 3.25% | 7.04% | 9.52% |
| SG&A Expenses | -5.99% | 11.49% | 25.79% | 42.77% | 17.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.49% | 9.60% | 20.23% | 23.31% | 11.52% |
| Operating Income | -151.20% | -48.53% | -67.12% | -60.47% | -22.01% |
| Income Before Tax | 66.22% | -276.17% | -176.38% | -78.24% | -449.55% |
| Income Tax Expenses | 872.10% | -85.32% | -55.52% | -32.21% | 125.45% |
| Earnings from Continuing Operations | 19.11% | 76.69% | -75.29% | -94.58% | -313.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 90.00% | -260.00% | 47.83% | -131.58% | -650.00% |
| Net Income | 19.32% | 76.26% | -72.34% | -101.24% | -314.04% |
| EBIT | -151.20% | -48.53% | -67.12% | -60.47% | -22.01% |
| EBITDA | -64.40% | -23.67% | -31.43% | -35.69% | 10.34% |
| EPS Basic | 20.37% | 76.32% | -62.96% | -84.21% | -292.86% |
| Normalized Basic EPS | -1,700.00% | -100.00% | -129.17% | -81.48% | -94.34% |
| EPS Diluted | 20.37% | 76.32% | -62.96% | -84.21% | -292.86% |
| Normalized Diluted EPS | -1,700.00% | -100.00% | -129.17% | -81.48% | -93.62% |
| Average Basic Shares Outstanding | 1.39% | 2.02% | 5.05% | 9.46% | 10.77% |
| Average Diluted Shares Outstanding | 1.39% | 2.02% | 5.05% | 9.46% | -1.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -2.95% | -- | -- | -- |